XML 105 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity and Other Employee Benefits (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Stock-Based Compensation Expense Related to Grants of Employee Stock Options, Restricted Stock Units (ZSUs) and Performance-Based Awards

We recorded stock-based compensation expense related to grants of employee stock options, ZSUs and performance-based awards in our consolidated statements of operations as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of revenue

 

$

1,471

 

 

$

1,584

 

 

$

1,838

 

Research and development

 

 

47,049

 

 

 

42,151

 

 

 

42,176

 

Sales and marketing

 

 

11,277

 

 

 

8,495

 

 

 

7,281

 

General and administrative

 

 

21,685

 

 

 

16,009

 

 

 

13,220

 

Total stock-based compensation expense

 

$

81,482

 

 

$

68,239

 

 

$

64,515

 

Schedule of Share Based Compensation Stock Option Activity

The following table shows stock option activity for the year ended December 31, 2019 (in thousands, except weighted-average exercise price and weighted-average contractual term):

 

 

 

Outstanding Options

 

 

 

Stock Options

 

 

Weighted-

Average

Exercise Price

 

 

Aggregate

Intrinsic

Value of

Stock Options

Outstanding

 

 

Weighted-

Average

Contractual

Term (in years)

 

Balance as of December 31, 2018

 

 

36,185

 

 

$

2.35

 

 

$

57,510

 

 

 

6.23

 

Granted

 

 

4,647

 

 

 

5.37

 

 

 

 

 

 

 

 

 

Forfeited, expired and cancelled

 

 

(42

)

 

 

2.85

 

 

 

 

 

 

 

 

 

Exercised

 

 

(9,586

)

 

 

0.90

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2019

 

 

31,204

 

 

$

3.24

 

 

$

89,786

 

 

 

7.19

 

As of December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options

 

 

15,666

 

 

$

2.78

 

 

$

52,363

 

 

 

6.59

 

Vested and expected to vest

 

 

31,204

 

 

$

3.24

 

 

$

89,786

 

 

 

7.19

 

Weighted-Average Grant Date Fair Value of Stock Options and Related Assumptions

 

The following table presents the weighted-average grant date fair value and related assumptions used to estimate the fair value of our stock options: 

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Expected term, in years

 

 

6

 

 

 

6

 

 

 

6

 

Risk-free interest rates

 

 

2.53

%

 

 

2.14

%

 

 

2.12

%

Expected volatility

 

 

43

%

 

 

47

%

 

 

46

%

Dividend yield

 

 

 

 

 

 

 

 

 

Weighted-average estimated fair value of stock options granted

   during the year

 

$

2.41

 

 

$

1.61

 

 

$

1.75

 

Schedule of Share Based Compensation Restricted Stock Units Award Activity

The following table shows a summary of ZSU activity for the year ended December 31, 2019 (in thousands, except weighted-average grant date fair value): 

 

 

 

Outstanding ZSUs

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

Average

Grant Date

 

 

Aggregate

Intrinsic

 

 

 

 

 

 

 

Fair Value

 

 

Value of

 

 

 

Shares

 

 

(per share)

 

 

Unvested ZSUs

 

Unvested as of December 31, 2018

 

 

52,482

 

 

$

3.49

 

 

$

206,254

 

Granted

 

 

14,086

 

 

 

5.61

 

 

 

 

 

Vested

 

 

(21,650

)

 

 

3.43

 

 

 

 

 

Forfeited

 

 

(4,730

)

 

 

3.81

 

 

 

 

 

Unvested as of December 31, 2019

 

 

40,188

 

 

$

4.23

 

 

$

245,951

 

Common Stock Reserved For Future Issuance

As of December 31, 2019, we had reserved shares of common stock for future issuance as follows (in thousands):

 

 

 

December 31, 2019

 

Stock options outstanding

 

 

31,204

 

ZSUs outstanding

 

 

40,188

 

2011 Equity Incentive Plan

 

 

152,769

 

2011 Employee Stock Purchase Plan

 

 

122,380

 

Total

 

 

346,541